Prostate Cancer - Results from #25660

Clinical features and prognostic factors for patients with bone metastases from prostate cancer - Abstract June 7, 2012

Vitamin D3 supplementation at 4000 international units per day for one year results in a decrease of positive cores at repeat biopsy in subjects with low-risk prostate cancer under active surveillance - Abstract June 7, 2012

Comparison of prostate volume measured by transrectal ultrasound and magnetic resonance imaging: Is transrectal ultrasound suitable to determine which patients should undergo active surveillance? - Abstract June 7, 2012

Prostate-specific antigen kinetics as a surrogate endpoint in clinical trials of metastatic castration-resistant prostate cancer: A review - Abstract June 7, 2012

Intermittent hormonal therapy in the treatment of metastatic prostate cancer: A randomized trial - Abstract June 7, 2012

Patient-reported quality of life during radiation treatment for localized prostate cancer: Results from a prospective phase II trial - Abstract June 7, 2012

Addition of radiotherapy to long-term androgen deprivation in locally advanced prostate cancer: An open randomised phase 3 trial - Abstract June 7, 2012

Combined (18) F-fluorocholine and (18) F-fluoride positron emission tomography/computed tomography imaging for staging of high-risk prostate cancer - Abstract June 7, 2012

The influence of testosterone suppression and recovery on sexual function in men with prostate cancer: Observations from a prospective study in men undergoing intermittent androgen suppression - Abstract June 7, 2012

Safety and efficacy of docetaxel in prostate cancer patients: Based on the post-marketing surveillance in Japan - Abstract June 6, 2012

A prospective, controlled phase II study of neoadjuvant exisulind therapy before radical prostatectomy: Effect on apoptosis - Abstract June 6, 2012

Prostate-specific antigen concentration in young men: New estimates and review of the literature - Abstract June 5, 2012

Androgen deprivation therapy for volume reduction, lower urinary tract symptom relief and quality of life improvement in patients with prostate cancer: Degarelix vs goserelin plus bicalutamide - Abstract June 5, 2012

How we manage prostate biopsy and prostate cancer therapy in men with haemophilia - Abstract June 5, 2012

The role of abiraterone in the management of metastatic castration-resistant prostate cancer - Abstract June 5, 2012

Progress in the treatment of bone metastases in cancer patients - Abstract June 5, 2012

Diffusion-weighted MRI of adult male pelvic cancers - Abstract June 5, 2012

Pelvic lymph node dissection for prostate cancer: Frequency and distribution of nodal metastases in a contemporary radical prostatectomy series - Abstract June 5, 2012

Accuracy of primary systematic template guided transperineal biopsy of the prostate for locating prostate cancer: A comparison with radical prostatectomy specimens - Abstract June 5, 2012

Contemporary open and robotic radical prostatectomy practice patterns among urologists in the United States - Abstract June 5, 2012

Page 1284 of 1435